NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1306057963 M.D.
Verify on CMS → Alice Zervoudakis, M.D.
Hematology & Oncology Physician in West Harrison, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
492
Medicare Part D claims · 109 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
91.6/100
▲ 8 pts above national avg 83.5 · Exceptional
What the federal data shows
Alice Zervoudakis, M.D. reported a CMS MIPS final score of 91.6/100 - above the 83.5 national average - and filed 492 Medicare Part D claims in 2023.
- 91.6/100
- MIPS score · +8 vs avg
- 492
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥61st
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1306057963 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1306057963
- ENUM-MID 2007
- TAX-MID 11K Hematology &
- MIPS-ABOVE 91.6/100
- RX-LIGHT 492
- BOOK-LIGHT 967 in New York
- PHOTO-FINISH Andrew Schneider · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Zervoudakis · th…
Zervoudakis · this provider
91.6 MIPS pts
- Fernando Recio ·…
Fernando Recio
91.6 MIPS pts
- James Chang · near
James Chang
91.6 MIPS pts
- Gurinderjit Kaur…
Gurinderjit Kaur Sidhu
91.6 MIPS pts
- Andrew Schneider…
Andrew Schneider
91.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Alice Zervoudakis, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
92 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Alice Zervoudakis, M.D. sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Alice Zervoudakis, M.D. writes more Part D claims than 38% of them and scores higher on MIPS quality than 63% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Alice Zervoudakis, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Alice Zervoudakis, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Alice Zervoudakis, M.D.?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
492 42% vs specialty avg
MIPS final score
91.6/100 8.1 pts vs avg
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Alice Zervoudakis, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 91.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1306057963 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/25/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.5789
Final Score
Measured-score avg: 83.5
86.4346
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Alice Zervoudakis, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Memorial Solid Tumor Group
New York, NY
Msk Harrison
West Harrison, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Alice Zervoudakis, M.D.. To verify Alice Zervoudakis, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
492
Total Claims
$301K
Total Drug Cost
109
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 535
- Total Day Supply
- 13,902
- Generic Drug Cost
- $15K
- Opioid Claims
- 20 (4.1% rate)
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 2.30
- Gender Split
- 56% female / 44% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Alice Zervoudakis, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
88 claims
- Prochlorperazine M…
Prochlorperazine Maleate
50 claims
- Ondansetron Hcl
Ondansetron Hcl
47 claims
- Lorazepam 20
Lorazepam
20 claims
- Ursodiol 20
Ursodiol
20 claims
- Creon 19
Creon
19 claims
- Zolpidem Tartrate 18
Zolpidem Tartrate
18 claims
- Omeprazole 16
Omeprazole
16 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 88 |
| Prochlorperazine Maleate | 50 |
| Ondansetron Hcl | 47 |
| Lorazepam | 20 |
| Ursodiol | 20 |
| Creon Lipase/Protease/Amylase | 19 |
| Zolpidem Tartrate | 18 |
| Omeprazole | 16 |
| Prednisone | 15 |
| Mirtazapine | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Alice Zervoudakis, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Alice Zervoudakis, M.D.'s 492 claims are below the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Zervoudakis, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.6 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Zervoudakis.
One of 967 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Dr. Anum Aamir
M.D
Astoria, NY
Dr. Robert Abderhalden
MD
Painted Post, NY
Dr. Mohammad Maher Abdul Hay
MD
New York, NY
Dr. George Abraham
MD
Rochester, NY
Dr. Avram Abramowitz
M.D.
Fresh Meadows, NY
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Alice Zervoudakis, M.D.'s specialty? ▼
Alice Zervoudakis, M.D. specializes in Hematology & Oncology Physician and practices in West Harrison, New York. Credentials: M.D..
How much does Alice Zervoudakis, M.D. prescribe under Medicare Part D? ▼
In 2023, Alice Zervoudakis, M.D. wrote 492 Medicare Part D claims totaling $301K in drug costs for 109 beneficiaries.
What is Alice Zervoudakis, M.D.'s Medicare quality score? ▼
Alice Zervoudakis, M.D. has a CMS MIPS Final Score of 91.6/100 (Quality: 86.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Alice Zervoudakis, M.D. located? ▼
Alice Zervoudakis, M.D. is located at 500 WESTCHESTER AVE, West Harrison, NY, 10604. Phone: (917) 367-7000.
What is Alice Zervoudakis, M.D.'s NPI number? ▼
Alice Zervoudakis, M.D.'s National Provider Identifier (NPI) is 1306057963, issued on 05/25/2007.
Does Alice Zervoudakis, M.D. prescribe opioids? ▼
Yes, Alice Zervoudakis, M.D. had 20 opioid claims in 2023 with an opioid prescribing rate of 4.1%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Alice Zervoudakis, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Alice Zervoudakis, M.D.'s most frequently prescribed drugs include Pantoprazole Sodium, Prochlorperazine Maleate, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Alice Zervoudakis, M.D. accept Medicare? ▼
Alice Zervoudakis, M.D. appears in CMS Medicare data with 492 Part D claims and 109 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Alice Zervoudakis, M.D.'s credentials? ▼
Alice Zervoudakis, M.D.'s NPI is 1306057963 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.